Nurix Therapeutics NRIX
NASDAQ NRIX
$22.99 -0.35 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) posted Interest & Investment Income of $4.4 million for fiscal Q2 2026 (quarter ended May 31, 2026), down 21.7% from $5.62 million a year earlier and down 17.3% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2026) Analysis & Trends

For the trailing twelve months through May 31, 2026, Interest & Investment Income at Nurix Therapeutics was $19.56 million, down 18.5% year-over-year; for FY2025 (ended Nov 30, 2025), it was $21.97 million, up 11.4% from FY2024.

  • Annual Interest & Investment Income has increased for four consecutive fiscal years, with a five-year compound annual growth rate of 78.7% (FY2020 to FY2025).
  • In prior fiscal years, Nurix Therapeutics' Interest & Investment Income was $19.73 million in FY2024 (+77.5%), $11.12 million in FY2023 (+216.9%), $3.51 million in FY2022 (+326.1%) and $823,000 in FY2021 (-31.8%).
  • The fiscal Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since fiscal Q2 2024.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last four quarters, with growth averaging 25.7% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q1 2023, with growth of 951.7%; the weakest was fiscal Q3 2021, with a decline of 94.2%.
  • According to Business Quant data, Interest & Investment Income for the three prior fiscal quarters was $5.32 million (Q1 2026), $4.87 million (Q4 2025) and $4.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Nurix Therapeutics 2.38 Bn 378.07 Mn - 4.40 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 4.40 Mn
Feb 28, 2026 5.32 Mn
Nov 30, 2025 4.87 Mn
Aug 31, 2025 4.96 Mn
May 31, 2025 5.62 Mn
Feb 28, 2025 6.51 Mn
Nov 30, 2024 6.12 Mn
Aug 31, 2024 5.74 Mn
May 31, 2024 4.08 Mn
Feb 29, 2024 3.79 Mn
Nov 30, 2023 3.38 Mn
Aug 31, 2023 3.03 Mn
May 31, 2023 2.49 Mn
Feb 28, 2023 2.22 Mn
Nov 30, 2022 1.97 Mn
Aug 31, 2022 1.01 Mn
May 31, 2022 314,000.00
Feb 28, 2022 211,000.00
Nov 30, 2021 295,000.00
Aug 31, 2021 39,000.00
API Access

Nurix Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NRIX&period=max&api_key=YOUR_API_KEY